|
Victor V. Gogolak, Founder and Chief Executive Officer, brings over 30 years of scientific, technology and industry experience to DrugLogic. He was a vice-president in the commercial sector of Booz, Allen & Hamilton (BAH), where he led the company's thrust into drug safety and surveillance. He was responsible for marketing and managing over $13 million annually in project sales; his implementation projects included developing a world-class web-based adverse event reporting system for pharmaceutical companies. Prior to joining BAH, he was one of the six founding shareholders of the Titan Corp., where he developed a line of business supporting government and defense use of technology. He holds a B.S. in physics, a B.S. in philosophy and an M.S. in mathematics from Fordham University. | 